Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial.

Li ZangYijun LiHaojie HaoJiejie LiuYu ChengBing LiYaqi YinQian ZhangFei GaoHaibin WangShi GuJia LiFengxiang LinYingfei ZhuGuanglei TianYulong ChenWeijun GuJin DuKang ChenQinghua GuoGuoqing YangYu PeiWenhua YanXianling WangJunhua MengSaichun ZhangJianming BaZhaohui LyuJingtao DouWeidong HanYi-Ming Mu

Published in: Stem cell research & therapy (2022)

UC-MSCs transplantation could be a potential therapeutic approach for Chinese adults with T2DM. Trial registration This study was registered on ClinicalTrials.gov (identifier: NCT02302599).

Keyphrases

placebo controlled
umbilical cord
phase iii
mesenchymal stem cells
double blind
phase ii
open label
study protocol
clinical trial
phase ii study
randomized controlled trial
stem cells
metabolic syndrome
squamous cell carcinoma
skeletal muscle
radiation therapy
rectal cancer